retatrutide who makes it is being called the next generation of weight loss drugs and for good reason. Here's why it's different. Follow to stay ahead of what's coming in weight loss medicine. #Retatrutide #GLP1 # Retatrutide for weight loss: Study

This week, GLP-1 heavyweight Novo Nordisk (NYSE: NVO) sued the leading GLP-1 drugmaker, Eli Lilly (NYSE: LLY), claiming its television ads are deceptive because they state that Lilly's Zepbound is more effective for weight loss than Novo's Wegovy

The metabolism of Vitamin B is critical in converting food into energy, making Vitamin B12 one of the key players in combating fatigue

This approach prioritizes consistency and comprehensive pathway coverage

Diabetes 53:410417 Cryer PE (2012) Minireview: glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes

The absence of GIPs effect on gastric emptying underscores the physiological and pharmacological distinctions between GIP and GLP-1

Practical tip : Aim for fatty fish twice a week